Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac adjunct to topical steroid after cataract surgery in pseudoexfoliation syndrome
IRCT20160919029871N3Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of ketorolac, betamethasone and chloramphenicol in pseudoexfoliation syndrome (PXF) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Anterior chamber inflammation grade. Started Jan 2018; status: completed.
02
Drugs
ketorolacbetamethasonechloramphenicol
03
Conditions
pseudoexfoliation syndrome (PXF)
Beyond the preview
Go deeper on IRCT20160919029871N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160919029871N3.